An announcement from Novo Integrated Sciences (NVOS) is now available.
Novo Integrated Sciences, Inc. has amended its securities agreement with RC Consulting Consortium Group, allowing the company to repay up to 50% of its $70 million promissory note with restricted stock if its share price exceeds $15 for five consecutive days. This amendment offers flexibility for early repayment, with sales of such stock being regulated post-restriction. Remaining terms of the original 15-year note, including the right to full prepayment, are unchanged. The company has publicly announced the amendment, emphasizing that the release of this information is not an admission of its materiality for regulatory purposes.
For a thorough assessment of NVOS stock, go to TipRanks’ Stock Analysis page.
